EGFR and cancer: The epidermal growth factor receptor (EGFR) is oncogenic receptor tyrosine kinase that is often overexpressed/overactivated in cancers of epithelial origin, and drugs targeting the tyrosine kinase activity of EGFR have been developed as putative therapeutics to treat such malignancies.